Nrf2/HO-1 pathway activation can significantly reduce inflammatory responses in various pathological events, such as cancer, cardiovascular diseases, and renal ischemia–reperfusion injury [15,16]. The gene discussed is HMOX1; the disease is cardiovascular disorder.